Synthetic biology and America’s future: New opportunities for working with the U.S. government

The next 12 months will see a global stimulus investment in technology and the global bioeconomy. You’re perfectly placed to capitalize on this, and SynBioBeta will bring you many new opportunities to participate. Join SynBioBeta Founder John Cumbers for an expert roundtable discussion on opportunities for growing the synthetic biology industry while supporting sustainable US leadership in this area. We will strategize ways the synthetic biology community can best take part in government initiatives, including:

• The Department of Defense’s investment to modernize the US military

• The Endless Frontier Act and the Bioeconomy Research & Development Bill

• New funding opportunities available to companies to support commercial development

• Scalable, sustainable solution areas synthetic biology is particularly suited for

• Growing the bioeconomy at the government-industry interface

• Harmonizing the goals of the synthetic biology community with federal initiatives

Expert panelists include:

• Jason Kelly, Founder and CEO of Ginkgo Bioworks

• Justin Sanchez, Life Sciences Research Technical Fellow at Battelle

• Megan Palmer, Executive Director, Bio Policy & Leadership Initiatives, Department of Bioengineering at Stanford University

• Michael Koeris, Consultant at Battelle

• Douglas Friedman, Executive Director of the Engineering Biology Research Consortium (EBRC)

I hope you can join us for this unique opportunity on Thursday, July 9th, at 10 am PDT. Please REGISTER HERE.